Natalia "Natasha" Muehlemann, MD, MBA has over 20 years of experience in General Management, Clinical Development, Business Development & Licensing in Life Sciences across several therapeutic areas.
In her position of VP, Strategic Consulting at Cytel, Natalia focuses on the on the integration of innovative adaptive frequentists and Bayesian designs, Machine Learning methods and RWE into comprehensive clinical development strategies. Prior to Cytel, Natalia was global Category Head, Acute Care – Oncology – Devices at Nestle Health Sciences. Natalia has been acting as Expert Jury member for European Commission's Innovation Council and SMEs Executive Agency and other Investors forums.
Natalia holds an MD and MBA (IMD), and professional certifications in statistics, data science and AI/ML from Stanford, IBM and MIT.
